Go back to the noodls home page
  • About us
  • Coverage
  • Services
Login

Not yet a member?Join now!|Lost password


  • Home


  • News

    • International News

    • Education

    • Environment

    • Health

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics 
    and Policy

    • Government and Public Administration

    • Politics

    • Local Administration

    • International Policy

  • Business 
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labour

    • Company News

    • Industries

      • Aerospace

      • Agriculture

      • Chemicals

        • Plastics and Rubber

      • Consumer Goods

      • Construction

      • Defense

      • Consumer Electronics

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable and Alternative Energy

      • Financial Service and Investment

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Information Technology

      • Industrial and Manufacturing

        • Engineering and Heavy Industry

      • Metals

      • Mining

      • Pharmaceuticals

      • Real Estate

      • Services

        • Legal

        • Marketing and Communications

      • Telecommunications

      • Textile

      • Tobacco

      • Trade and Commerce

        • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Wood Industry

  • Arts 
    and Culture

    • Art

    • Book and Literature

    • Media and Entertainment

      • Cinema

      • Music

      • Radio and Television

    • Media

  • Lifestyle 
    and Leisure

    • Auto and Motors

    • Home and Garden

    • Fashion and Luxury

      • Clothing and Accessories

      • Cosmetics

      • Jewelry and Watches

    • Food and Drink

    • Travel and Tourism

    • Yacht and Sailing


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Rugby

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

Novo Nordisk A/S

12/04/2012 | Press release

Novo Nordisk to create the world's first all-diabetes professional cycling team (4 December 2012)

distributed by noodls on 12/04/2012 05:53

Print Print

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website

Close

Bagsværd, Denmark, 4 December 2012 â€" Novo Nordisk today announced a unique partnership to form Team Novo Nordisk, a global sports team with more than 100 cyclists, triathletes and runners who all have diabetes, spearheaded by the world’s first all-diabetes pro-cycling team.

Team Novo Nordisk will use life experiences and competitiveness to motivate people affected by diabetes. Throughout 2013, these athletes will compete in more than 500 sporting competitions around the world. The men’s pro-cycling team will compete in races such as the USA Pro Cycling Challenge, the Tour of Britain and the Paris-Tours, with the ultimate goal of joining the Tour de France.

“As part of our long-standing Changing Diabetes® programme, this partnership provides a tremendous opportunity to raise awareness, and educate, empower and inspire people with diabetes,†says Jakob Riis, senior vice president, Global Marketing and Global Medical Affairs, Novo Nordisk. “This is yet another way Novo Nordisk is striving to create more opportunities to live well with diabetes.â€

Phil Southerland founded what was known as ‘Team Type 1’ in 2005 and included riders and athletes with and without diabetes until this year. The new Team Novo Nordisk will only comprise of athletes who have diabetes and will continue to grow the team mission “to instil hope and inspiration for people around the world affected by diabetes.â€

“As Team Novo Nordisk we want to show the world what is possible with great diabetes control. Between us, Team Novo Nordisk has over 1,000 diagnosed years of diabetes with no complications and we stand for what life with diabetes can be like,†Southerland says. “Exercise is that billion dollar drug that nobody ever gets prescribed, and in my experience is the best of them all. With appropriate diet, exercise, treatment and technology, anyone with diabetes can achieve their dreams.â€

See also:

www.twitter.com/teamnovonordisk

www.facebook.com/teamnovonordisk

About Diabetes

Today, 371 million people are living with diabetes.1 Changing Diabetes® is Novo Nordisk’s global commitment to improve conditions for the millions of people who live with diabetes around the world today, and those who are at risk of developing diabetes tomorrow. It is a global advocacy and partner platform which advocates for the prevention and early detection of diabetes, as well as improved treatment, care and health outcomes.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.

Reference

1.     International Diabetes Federation. IDF Diabetes Atlas, 5th Edition, 2012 Update. Brussels, Belgium: International Diabetes Federation. Available from: http://www.idf.org/diabetesatlas. Last accessed: November 2012

Further information

Media:

Katrine Sperling

+45 4442 6718

krsp@novonordisk.com

Ken Inchausti (US)

+1 609 514 8316

kiau@novonordisk.com

Investors:

Kasper Roseeuw Poulsen

+45 4442 4303

krop@novonordisk.com

Frank Daniel Mersebach

+45 4442 0604

fdni@novonordisk.com

Lars Borup Jacobsen

+45 3075 3479

lbpj@novonordisk.com

Jannick Lindegaard (US)

+1 609 786 4575

jlis@novonordisk.com

Smartlinks | Novo Nordisk A/S | Company News | Health | News | Pharmaceuticals | Science | Stocks and Security Markets | Healthcare Industry | Biology | Business and Corporate Announcement | Pharmaceutical Companies | New York Stock Exchange (NYSE) | Börse Frankfurt | Nasdaq OMX Nordic | Börse Düsseldorf | Börse München | Deutsche Börse (XETRA) | OTC Markets | Chi-X | Forbes Global 2000 | Large Cap and Index Constituents | NYSE ARCA

Back

View original format

Copyright ©2006-2013 noodls.com - VAT IT01709820995 | Privacy Policy | Terms of Use | Feedback | Contact us